Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ocular Oncology
•
Ophthalmology
•
Cornea and External Disease
How do you decide on treatment modality for ocular surface squamous neoplasia?
Related Questions
How do you determine the role of adjunctive therapies for a patient with conjunctival squamous cell carcinoma (SCC) that has recurred after initial surgical excision?
What strategies do you use to optimize cataract surgery outcomes in patients with anterior basement membrane dystrophy (ABMD)?
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
How do you approach perioperative steroids for a quiescent uveitis patient undergoing cataract surgery?
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
How do you approach IOL calculations and selection in patients with keratoconus based on disease severity?
How do you approach the management of a patient with a small, indeterminate choroidal mass with no obvious primary malignancy?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
What factors should be considered when deciding whether to perform corneal crosslinking (CXL) in mild cases of keratoconus?
